Beli & Jual Indofarma Tbk. - Harga INAF Hari Ini
Statistik Pasar
- 390,51 MMarket Cap
- -Volume
- -Lot
- -Turnover
- -Rata-Rata
- -Nilai
- -IEP
- -IEV
Indofarma Tbk. (INAF) memiliki kapitalisasi pasar sebesar 390,51 M. Statistik utama ini membantu investor menilai likuiditas, perilaku perdagangan, dan sentimen pasar terhadap INAF di Bursa Efek Indonesia (BEI).
Profil Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Berita
Inaf sampaikan rencana realisasi pemulihan
Perkuat restrukturisasi, indofarma bidik pertumbuhan pendapatan 112% di 2026
Indofarma siap lanjutkan upaya restrukturisasi di 2026
Indofarma klarifikasi isu phk massal, tegaskan bagian dari restrukturisasi perusahaan
Indofarma (inaf) perkuat integritas lewat deklarasi anti korupsi di kpk
Indofarma raih penjualan bersih rp133,73 miliar hingga september 2025
Banyak orang juga membeli
